• 1
    Hirsch HH et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 48896.
  • 2
    Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103109.
  • 3
    Drachenberg CB et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol 1999; 30: 970977.
  • 4
    Nickeleit V et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 10801089.
  • 5
    Mylonakis E et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72: 15871592.
  • 6
    Binet I et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918922.
  • 7
    Purighalla R et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26: 671673.
  • 8
    Mathur VS et al. Polyomavirus-induced interstitial nephritis in two renal transplant recipients – case reports and review of the literature. Am J Kidney Dis 1997; 29: 754758.
  • 9
    Pappo O et al. Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9: 105109.
  • 10
    Leung AY et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 19711978.
  • 11
    Limaye AP et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183: 16691672.
  • 12
    Mayr M et al. Polyomavirus BK nephropathy in a kidney transplant recipient: critical issues of diagnosis and management. Am J Kidney Dis 2001; 38: E13.
  • 13
    Fink JC et al. The increased incidence of BK polyoma virus in renal transplant recipients treated with prograft Transplantation 2000; 69: 385.
  • 14
    Heritage J, Chesters PM, McCance DJ. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 1981; 8: 143150.
  • 15
    Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147: 676684.
  • 16
    Shah KV et al. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 1997; 176: 16181621.
  • 17
    Drummond JE, KV. Shah, AD. Donnenberg. Cell-mediated immune responses to BK virus in normal individuals. J Med Virol 1985; 17: 237247.
  • 18
    Drummond JE et al. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients. J Med Virol 1987; 23: 331344.
  • 19
    Comoli P et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003; 14: 31973204.
  • 20
    Nickeleit V et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324332.
  • 21
    Waldman WJ et al. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992; 54: 887896.
  • 22
    Waldman WJ et al. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation 1993; 56: 15041512.
  • 23
    Cecka JM. The role of HLA in transplantation [Review]. Hum Immunol 1997; 56: 616.
  • 24
    Opelz G. Impact HLA compatibility survival kidney transplants from unrelated live donors. Transplantation 1997; 64: 14731475.
  • 25
    Markus BH et al. Histocompatibility and liver transplantation: a dualistic effect of HLA Transplantation 1988; 46: 372377.
  • 26
    Donaldson P et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: ‘the dualistic effect’. Hepatology 1993; 17: 10081015.
  • 27
    O'Grady J et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile–duct syndrome after liver transplantation. Lancet 1988; 2: 302305.
  • 28
    Manez R et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993; 55: 10671071.
  • 29
    Calmus Y et al. HLA class I mtching is resposnible for the hepatic lesions in recurrent hepatitis B after liver transplantation. Transplant Proc 1990; 22: 23112313.
  • 30
    Manez R et al. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995; 59: 640642.
  • 31
    Kraat YJ et al. Inreased frequency of CMV infection in HLA-DR7 matched renal allograft recipients. Lancet 1993; 341: 494495.
  • 32
    Schnitzler M et al. Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching. J Am Soc Nephrol 2003; 4: 780785.
  • 33
    Fleiss JL, ed. Statistical Methods for Rates and Proportions, 2nd edn. New York : John Wiley & Sons, 1981.
  • 34
    Ramos E, Drachenberg C, Portocallero et al. BK virus nephropathy diagnosis and treatment. Experience at the University of Maryland Transplant Program. Clin Transpl 2002: 143153.
  • 35
    Ahuja M et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896899.
  • 36
    Noss G. Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 266: 567574.
  • 37
    Haririan A et al. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73: 13501353.